Top compounds associated with response to RFPL4B


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.07 0.2
mRNA bendamustine CTRPv2 pan-cancer AAC 0.052 0.2
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.042 0.2
mRNA VX-11e GDSC1000 pan-cancer AAC -0.046 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA rigosertib CTRPv2 pan-cancer AAC 0.045 0.2
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA BMS-536924 GDSC1000 pan-cancer AAC -0.044 0.2
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA erastin CTRPv2 pan-cancer AAC -0.047 0.2
Download CSV